Latest news with #AnnualShareholders'Meeting
Business Wire
24-06-2025
- Business
- Business Wire
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting
LYON, France--(BUSINESS WIRE)--Regulatory News: MaaT Pharma (EURONEXT: MAAT – the 'Company'), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem Therapies ™ (MET) dedicated to enhancing survival for patients with cancer through immune modulation, today presents the results of its Annual and Extraordinary General Meeting held on Friday, June 20, 2025 at 9:30 am CET at the Company's office and broadcasted live (replay available here). The quorum reached by the shareholders present, representing, or voting remotely, was above 73% of voting shares. Shareholders overwhelmingly approved most of the resolutions put forward by the Board of Directors by a majority of over 99% (with the exception of the 29th and 34th resolutions approved by nearly 69% of voters). The following resolutions were approved: Approval of the financial statements for fiscal year 2024; The compensation policy for corporate officers (Chairman, Chief Executive Officer and Directors) and the compensation paid or awarded during 2024 fiscal year – details of the votes on the said resolution is available on the Company's website here; Financial resolutions, notably delegations of authority to the Board of Directors to carry out capital increases in various situations; Delegation of authority to the Board of Directors to decide on any merger, demerger or partial contribution of assets (29th resolution). Only one resolution was rejected: Delegation of authority to the Board of Directors to carry out a capital increase through the issue of shares or securities giving access to the capital, reserved for members of a company savings plan, with the cancellation of preferential subscription rights in their favor (36th resolution). Shareholders also approved the renewal of the terms of office for current directors Mr. Jean-Marie Lefèvre, Mrs. Dorothée Burkel, Mrs. Nadia Kamal, Mr. Claude Bertrand, Mr. Hervé Affagard, Mr. Jean Volatier, Seventure Partners, and the appointment of a representative from Bpifrance Investissement as a director. It is also noted that the presidency of Mr. Karim Dabbagh came to an end at the close of the Annual Shareholders' Meeting on June 20, 2025, as his mandate is reaching its term. The Board and the Company thank Mr. Dabbagh for his contribution and his service as Chairman and wishes him every success in his future endeavors. Following the Annual General Meeting, the Board of Directors meeting that took place on June 24 th, 2025, appointed Mr. Jean-Marie Lefèvre as Chairman of the Board for the duration of his term of office, which he had previously led for 5 years between 2018-2023. In accordance with the approval of resolutions 19 and 20, the Company also announces that the Board of Directors has decided to maintain the liquidity contract signed with Kepler Cheuvreux for the liquidity of the Company's shares listed on Euronext Paris. Information on this contract is available in the Company's Universal Registration Document (French only). The full minutes of the Annual General Meeting and the results of the votes, resolution by resolution, will be made available shortly on the Company's website in the Investors/Shareholder Meetings' section. About MaaT Pharma MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed on Euronext Paris (ticker: MAAT) since 2021. Forward-looking Statements All statements other than statements of historical fact included in this press release about future events are subject to (i) change without notice and (ii) factors beyond the Company's control. These statements may include, without limitation, any statements preceded by, followed by, or including words such as 'target,' 'believe,' 'expect,' 'aim', 'intend,' 'may,' 'anticipate,' 'estimate,' 'plan,' 'project,' 'will,' 'can have,' 'likely,' 'should,' 'would,' 'could' and other words and terms of similar meaning or the negative thereof. Forward-looking statements are subject to inherent risks and uncertainties beyond the Company's control that could cause the Company's actual results or performance to be materially different from the expected results or performance expressed or implied by such forward-looking statements.
Scoop
22-06-2025
- Business
- Scoop
TradeWindow Raises $600k In Placement To Accelerate Growth
TradeWindow (NZX: TWL), a global trade software company, today announces it has raised $600,000 in new equity in a private placement to new investors to accelerate its growth and strengthen its balance sheet. The company continues to explore further sources of capital including both debt and equity. The company has agreed to issue 3,333,329 shares at a price of $0.18 per share. Settlement and allotment of the new shares is expected to take place on or about 23 June 2025. USE OF FUNDS TradeWindow intends to use the new capital to: • Accelerate the development of our next generation AI-enabled freight operating system. This new platform is targeted at integrating with modern platforms like TW Cube and solutions used by ocean carriers, terminal operators, and government agencies. We expect the new platform to sharpen our competitive edge in leading the digital transformation of global trade information flows. • Drive the acquisition of market share in Australia where the company continues to see strong opportunities. • Establish beachheads in new markets where rapidly shifting global trade policies are creating strong demand for trade compliance tools. • Strengthen the company's balance sheet to provide a larger buffer against market disruptions. Chief Executive and Managing Director AJ Smith said: 'We are delighted with the support we have received from new investors in this placement. It follows on from a strong FY25 when TradeWindow delivered revenue growth of 30% to reach a record of $8.0 million in revenue and cleared the path to financial sustainability through strong capital discipline. It is a ringing endorsement of our strategy and our confidence in the strong potential we see for TradeWindow to grow rapidly in our core Australasian market and further afield.' TradeWindow continues to expect FY26 revenue to range between $10 million and $11 million – representing growth of 25% to 37.5% over FY25 revenue. It also continues to expect to achieve EBITDA breakeven for the 2026 financial year. TradeWindow will provide a further update on trading at its Annual Shareholders' Meeting in August. TradeWindow undertook a selective process to identify new prospective investors for the offer through MSL Capital Markets Limited. TradeWindow considers that a placement to new investors is in the best interests of TradeWindow and its existing shareholders, as the placement allowed TradeWindow to access a broader pool of potential investors, giving greater certainty around the achievement of the targeted raising size and more favourable pricing for TradeWindow. About TradeWindow: Founded in December 2018, TradeWindow is an NZX-listed software company that provides digital solutions for exporters, importers, freight forwarders, and customs brokers to drive productivity, increase connectivity, and enhance visibility. TradeWindow's software solutions integrate to form a cohesive digital trade platform that enables customers to more efficiently run their back-end operations, share information and securely collaborate with a global supply chain made up of customers, ports, terminals, shipping lines, banks, insurance companies, and government authorities.
Yahoo
10-06-2025
- Business
- Yahoo
Latecoere: Annual Shareholders' Meeting
All resolutions submitted to the Annual Shareholders' Meeting were approved. TOULOUSE, France, June 10, 2025--(BUSINESS WIRE)--Regulatory News: The 2025 Annual General Meeting of LATECOERE (Paris:LAT) shareholders was held at the Company's registered office on June 6, 2025, and all resolutions submitted were approved. Detailed voting results are available on the Company's website: Regulated information - Latecoere. About Latecoere Tier 1 to the world's leading OEMs (Airbus, BAE Systems, Boeing, Bombardier, Dassault Aviation, Embraer, Honda Aircraft Company, Lockheed Martin, RTX, Thales), Latecoere serves aerospace with innovative solutions for a sustainable world. The Group operates in all segments of the aerospace industry (commercial, regional, business, defense and space) in three business areas: Aerostructures Europe and Americas: doors, fuselage, wings and empennage, rods; Interconnection Systems: wiring, avionic racks, on-board systems; Special Products and Services: customer services, on-board equipment, electronic systems. As of December 31, 2024, the Group employed 5,497 people in 14 countries. Latecoere is listed on Euronext Paris - Compartment B, ISIN Code: FR001400JY13 - Reuters: - Bloomberg: View source version on Contacts Media Relations Thierry Mahé+33 (0)6 60 69 63 85LatecoereGroupCommunication@ Investor Relations mandataires-ag-latecoere@ Sign in to access your portfolio
Yahoo
30-05-2025
- Business
- Yahoo
Number of shares and votes in EQT
Cancellation of 6,899,011 ordinary shares held in treasury by EQT The cancellation was resolved by the Annual Shareholders' Meeting 2025 As of 30 May 2025, there are 1,177,185,346 shares outstanding in EQT STOCKHOLM, May 30, 2025 /PRNewswire/ -- The total number of shares and votes in EQT AB (publ) ("EQT") has decreased by 6,899,011 shares and votes during May 2025 as a result of a cancellation of 6,899,011 ordinary shares held in treasury by EQT. The cancellation was resolved by the Annual Shareholders' Meeting 2025 on 27 May 2025, in line with EQT's intention to off-set over time the dilution impact from shares delivered to participants in EQT's Share and Option Programs. The number of shares and votes in EQT as of 30 May 2025 is set out in the table below. Ordinary shares Class C shares1 Total Number of issued shares2 1,234,611,900 (1,234,611,900 votes) 496,056 (49,605.6 votes) 1,235,107,956 (1,234,661,505.6 votes) Number of shares owned by EQT AB3 57,922,610 - 57,922,610 Number of outstanding shares 1,176,689,290 (1,176,689,290 votes) 496,056 (49,605.6 votes) 1,177,185,346 (1,176,738,895.6 votes) 1 Carry one tenth (1/10) of a vote 2 Total number of shares in EQT AB, i.e. including the number of shares owned by EQT AB and the number of shares outstanding 3 EQT AB shares owned by EQT AB are not entitled to dividends or carry votes at shareholders' meetings This press release is published for regulatory reasons. Contact Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15EQT Press Office, press@ +46 8 506 55 334 This is information that EQT AB (publ) is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person set out above, at 18:00 CET on 30 May 2025. This information was brought to you by Cision The following files are available for download: EQT - Number of shares and votes (30 May 2025) EQT Group View original content:
Business Wire
16-05-2025
- Business
- Business Wire
TotalEnergies EP Gabon: Annual Shareholders' Meeting on Friday May 16, 2025
PORT-GENTIL, Gabon--(BUSINESS WIRE)--Regulatory News: TotalEnergies EP Gabon's (Paris:EC) ordinary Annual Shareholders' Meeting was held today in Port-Gentil, chaired by Mr. Mike SANGSTER. Shareholders approved all resolutions recommended by the Board of Directors, including: - Approval of the 2024 financial statements including a net income of $91 million under International Financial Reporting Standards (IFRS) referential and $86 million under OHADA standards. - Approval of the payment of a net dividend of $22.22 per share related to the financial year 2024 for a total amount of $100 million. - Renewal of the directors' mandates of Mrs. Renée Estelle NSI BENGONE, and Stéphanie MPEMBA MBADINGA, and MM. Mike SANSGTER, Thomas MAREEL, Yann DUCHESNE and Brice de Léon RETENO N'DIAYE for a two-year term expiring at the end of the Annual Shareholders' Meeting called to approve the 2026 financial statements. - Determination of the global compensation ceiling of the statutory auditors for preparing their reports on the 2024 financial statements. A detailed breakdown of the votes will be posted on the Company's website in the coming days. The Board of Directors in its meeting today approved the modalities of the dividend payment. The $22,22 per share dividend will be paid in euro as from June 9, 2025 in an equivalent amount of €19.85 per share, based on the European Central Bank's rate (or its corresponding value in CFA francs) of $1.1194 per euro on May 16, 2025. About TotalEnergies EP Gabon TotalEnergies EP Gabon is 58.28% owned by TotalEnergies SE, 25% by the Gabonese Republic and 16.72% by the public. About TotalEnergies TotalEnergies is a global integrated energy company that produces and markets energies: oil and biofuels, natural gas and green gases, renewables and electricity. Our more than 100,000 employees are committed to provide as many people as possible with energy that is more reliable, more affordable and more sustainable. Active in about 120 countries, TotalEnergies places sustainability at the heart of its strategy, its projects and its operations. TotalEnergies Networks X : @TotalEnergies LinkedIn : TotalEnergies Facebook : TotalEnergies Instagram : TotalEnergies Cautionary Note The terms 'TotalEnergies', 'TotalEnergies company' or 'Company' in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words 'we', 'us' and 'our' may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. TotalEnergies SE has no liability for the acts or omissions of these entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC).
